Traditionally, microbiologists have grown bacteria as suspension cultures in rich media, in order to optimize cell yield. This planktonic mode of growth also became part of the standard assay on which all existing antimicrobials were selected and developed, and continues to be the basis for the selection of antimicrobials for specific patient treatment.
MICROBIAL BIOFILMS:
CONSEQUENCES FOR HEALTH
Introduction
Traditionally,
microbiologists have grown bacteria as suspension cultures in rich media, in
order to optimize cell yield. This planktonic mode of growth also became part
of the standard assay on which all existing antimicrobials were selected and
developed, and continues to be the basis for the selection of antimicrobials
for specific patient treatment. We now recognize that in most environments,
including our bodies, bacteria typically exist as adherent microcolonies termed
biofilms, which afford bacteria a
number of growth advantages including an inherent lack of susceptibility to
antimicrobials. This antimicrobial tolerance differs from classical genetic
resistance in that this reduced susceptibility disappears when the biofilm is
returned to planktonic growth. Biofilm tolerance is multifactorial, which
includes the spatial and structural parameters of the biofilm as well as the
increased phenotypic diversity within the biofilm population. Biofilms are
believed to be associated with approximately 60% of human infections including
chronic, recurrent and devicerelated infections, therefore treatment of biofilm
infections has become an important focus in modern medicine. As planktonic
susceptibility testing, via the minimal inhibitory concentration (MIC) test,
provides little guidance in the selection of antimicrobials to treat biofilms,
a change in paradigm is required to determine appropriate treatment of biofilms
and for the discovery of nextgeneration antimicrobials.
Related Topics
TH 2019 - 2025 pharmacy180.com; Developed by Therithal info.